A study to find the best dose of fezolinetant to treat hot flashes in women going through menopause

Trial Identifier: 2693-CL-0206
Sponsor: Astellas Pharma Inc.
Start Date: November 2021
Primary Completion Date: November 2022
Study Completion Date: December 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Japan, Chiba Matsudo-shi, Chiba, Japan
Japan, Fukuoka Fukuoka-shi, Fukuoka, Japan
Japan, Fukuoka Kitakyusyu-shi, Fukuoka, Japan
Japan, Hokkaido Sapporo-shi, Hokkaido, Japan
Japan, Kagawa Takamatsu-shi, Kagawa, Japan
Japan, Kagoshima Kagoshima-shi, Kagoshima, Japan
Japan, Kanagawa Sagamihara-shi, Kanagawa, Japan
Japan, Kanagawa Yokohama-shi, Kanagawa, Japan
Japan, Kyoto Kyoto-shi, Kyoto, Japan
Japan, Miyagi Sendai-shi, Miyagi, Japan
Japan, Nagano Matsumoto-shi, Nagano, Japan
Japan, Okayama Kurashiki-shi, Okayama, Japan
Japan, Osaka Osaka-shi, Osaka, Japan
Japan, Osaka Takatsuki-shi, Osaka, Japan
Japan, Saitama Saitama-shi, Saitama, Japan
Japan, Shiga Kusatsu-shi, Shiga, Japan
Japan, Shiga Omihachiman-shi, Shiga, Japan
Japan, Tokyo Chiyoda-ku, Tokyo, Japan
Japan, Tokyo Chuo-ku, Tokyo, Japan
Japan, Tokyo Hachioji-shi, Tokyo, Japan
Japan, Tokyo Minato-ku, Tokyo, Japan
Japan, Tokyo Nerima-ku, Tokyo, Japan
Japan, Tokyo Nishitokyo-shi, Tokyo, Japan
Japan, Tokyo Setagaya-ku, Tokyo, Japan
Japan, Tokyo Toshima-ku, Tokyo, Japan
Japan, Toyama Kurobe-shi, Toyama, Japan
Japan, Toyama Uozu-shi, Toyama, Japan
Japan, Yamaguchi Shunan-shi, Yamaguchi, Japan